πŸ‡ΊπŸ‡Έ FDA
Patent

US 9192629

Isolated renal cells and uses thereof

granted A61KA61K35/12A61K35/22

Quick answer

US patent 9192629 (Isolated renal cells and uses thereof) held by REGENMEDTX, LLC expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENMEDTX, LLC
Grant date
Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/12, A61K35/22, A61P, A61P13/00